Global Drugs Based on CAR T-cell Market Growth (Status and Outlook) 2022-2028

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Years Considered
• 1.3 Research Objectives
• 1.4 Market Research Methodology
• 1.5 Research Process and Data Source
• 1.6 Economic Indicators
• 1.7 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Drugs Based on CAR T-cell Market Size 2017-2028
  • 2.1.2 Drugs Based on CAR T-cell Market Size CAGR by Region 2017 VS 2022 VS 2028
• 2.2 Drugs Based on CAR T-cell Segment by Type
  • 2.2.1 CD19-targeted
  • 2.2.2 BCMA-targeted
• 2.3 Drugs Based on CAR T-cell Market Size by Type
  • 2.3.1 Drugs Based on CAR T-cell Market Size CAGR by Type (2017 VS 2022 VS 2028)
  • 2.3.2 Global Drugs Based on CAR T-cell Market Size Market Share by Type (2017-2022)
• 2.4 Drugs Based on CAR T-cell Segment by Application
  • 2.4.1 Lymphoma
  • 2.4.2 Multiple Myeloma
• 2.5 Drugs Based on CAR T-cell Market Size by Application
  • 2.5.1 Drugs Based on CAR T-cell Market Size CAGR by Application (2017 VS 2022 VS 2028)
  • 2.5.2 Global Drugs Based on CAR T-cell Market Size Market Share by Application (2017-2022)

3 Drugs Based on CAR T-cell Market Size by Player

• 3.1 Drugs Based on CAR T-cell Market Size Market Share by Players
  • 3.1.1 Global Drugs Based on CAR T-cell Revenue by Players (2020-2022)
  • 3.1.2 Global Drugs Based on CAR T-cell Revenue Market Share by Players (2020-2022)
• 3.2 Global Drugs Based on CAR T-cell Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Drugs Based on CAR T-cell by Regions

• 4.1 Drugs Based on CAR T-cell Market Size by Regions (2017-2022)
• 4.2 Americas Drugs Based on CAR T-cell Market Size Growth (2017-2022)
• 4.3 APAC Drugs Based on CAR T-cell Market Size Growth (2017-2022)
• 4.4 Europe Drugs Based on CAR T-cell Market Size Growth (2017-2022)
• 4.5 Middle East & Africa Drugs Based on CAR T-cell Market Size Growth (2017-2022)

5 Americas

• 5.1 Americas Drugs Based on CAR T-cell Market Size by Country (2017-2022)
• 5.2 Americas Drugs Based on CAR T-cell Market Size by Type (2017-2022)
• 5.3 Americas Drugs Based on CAR T-cell Market Size by Application (2017-2022)
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Brazil

6 APAC

• 6.1 APAC Drugs Based on CAR T-cell Market Size by Region (2017-2022)
• 6.2 APAC Drugs Based on CAR T-cell Market Size by Type (2017-2022)
• 6.3 APAC Drugs Based on CAR T-cell Market Size by Application (2017-2022)
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia

7 Europe

• 7.1 Europe Drugs Based on CAR T-cell by Country (2017-2022)
• 7.2 Europe Drugs Based on CAR T-cell Market Size by Type (2017-2022)
• 7.3 Europe Drugs Based on CAR T-cell Market Size by Application (2017-2022)
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia

8 Middle East & Africa

• 8.1 Middle East & Africa Drugs Based on CAR T-cell by Region (2017-2022)
• 8.2 Middle East & Africa Drugs Based on CAR T-cell Market Size by Type (2017-2022)
• 8.3 Middle East & Africa Drugs Based on CAR T-cell Market Size by Application (2017-2022)
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers & Growth Opportunities
• 9.2 Market Challenges & Risks
• 9.3 Industry Trends

10 Global Drugs Based on CAR T-cell Market Forecast

• 10.1 Global Drugs Based on CAR T-cell Forecast by Regions (2023-2028)
  • 10.1.1 Global Drugs Based on CAR T-cell Forecast by Regions (2023-2028)
  • 10.1.2 Americas Drugs Based on CAR T-cell Forecast
  • 10.1.3 APAC Drugs Based on CAR T-cell Forecast
  • 10.1.4 Europe Drugs Based on CAR T-cell Forecast
  • 10.1.5 Middle East & Africa Drugs Based on CAR T-cell Forecast
• 10.2 Americas Drugs Based on CAR T-cell Forecast by Country (2023-2028)
  • 10.2.1 United States Drugs Based on CAR T-cell Market Forecast
  • 10.2.2 Canada Drugs Based on CAR T-cell Market Forecast
  • 10.2.3 Mexico Drugs Based on CAR T-cell Market Forecast
  • 10.2.4 Brazil Drugs Based on CAR T-cell Market Forecast
• 10.3 APAC Drugs Based on CAR T-cell Forecast by Region (2023-2028)
  • 10.3.1 China Drugs Based on CAR T-cell Market Forecast
  • 10.3.2 Japan Drugs Based on CAR T-cell Market Forecast
  • 10.3.3 Korea Drugs Based on CAR T-cell Market Forecast
  • 10.3.4 Southeast Asia Drugs Based on CAR T-cell Market Forecast
  • 10.3.5 India Drugs Based on CAR T-cell Market Forecast
  • 10.3.6 Australia Drugs Based on CAR T-cell Market Forecast
• 10.4 Europe Drugs Based on CAR T-cell Forecast by Country (2023-2028)
  • 10.4.1 Germany Drugs Based on CAR T-cell Market Forecast
  • 10.4.2 France Drugs Based on CAR T-cell Market Forecast
  • 10.4.3 UK Drugs Based on CAR T-cell Market Forecast
  • 10.4.4 Italy Drugs Based on CAR T-cell Market Forecast
  • 10.4.5 Russia Drugs Based on CAR T-cell Market Forecast
• 10.5 Middle East & Africa Drugs Based on CAR T-cell Forecast by Region (2023-2028)
  • 10.5.1 Egypt Drugs Based on CAR T-cell Market Forecast
  • 10.5.2 South Africa Drugs Based on CAR T-cell Market Forecast
  • 10.5.3 Israel Drugs Based on CAR T-cell Market Forecast
  • 10.5.4 Turkey Drugs Based on CAR T-cell Market Forecast
  • 10.5.5 GCC Countries Drugs Based on CAR T-cell Market Forecast
• 10.6 Global Drugs Based on CAR T-cell Forecast by Type (2023-2028)
• 10.7 Global Drugs Based on CAR T-cell Forecast by Application (2023-2028)

11 Key Players Analysis

• 11.1 Novartis
  • 11.1.1 Novartis Company Information
  • 11.1.2 Novartis Drugs Based on CAR T-cell Product Offered
  • 11.1.3 Novartis Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2022)
  • 11.1.4 Novartis Main Business Overview
  • 11.1.5 Novartis Latest Developments
• 11.2 Gilead Sciences
  • 11.2.1 Gilead Sciences Company Information
  • 11.2.2 Gilead Sciences Drugs Based on CAR T-cell Product Offered
  • 11.2.3 Gilead Sciences Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2022)
  • 11.2.4 Gilead Sciences Main Business Overview
  • 11.2.5 Gilead Sciences Latest Developments
• 11.3 Bristol-Myers Squibb
  • 11.3.1 Bristol-Myers Squibb Company Information
  • 11.3.2 Bristol-Myers Squibb Drugs Based on CAR T-cell Product Offered
  • 11.3.3 Bristol-Myers Squibb Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2022)
  • 11.3.4 Bristol-Myers Squibb Main Business Overview
  • 11.3.5 Bristol-Myers Squibb Latest Developments
• 11.4 J & J
  • 11.4.1 J & J Company Information
  • 11.4.2 J & J Drugs Based on CAR T-cell Product Offered
  • 11.4.3 J & J Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2022)
  • 11.4.4 J & J Main Business Overview
  • 11.4.5 J & J Latest Developments
• 11.5 JW Therapeutics
  • 11.5.1 JW Therapeutics Company Information
  • 11.5.2 JW Therapeutics Drugs Based on CAR T-cell Product Offered
  • 11.5.3 JW Therapeutics Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2022)
  • 11.5.4 JW Therapeutics Main Business Overview
  • 11.5.5 JW Therapeutics Latest Developments
• 11.6 FOSUNKite
  • 11.6.1 FOSUNKite Company Information
  • 11.6.2 FOSUNKite Drugs Based on CAR T-cell Product Offered
  • 11.6.3 FOSUNKite Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2022)
  • 11.6.4 FOSUNKite Main Business Overview
  • 11.6.5 FOSUNKite Latest Developments

12 Research Findings and Conclusion